MARKET

BBNX

BBNX

Beta Bionics, Inc.
NASDAQ
13.95
-0.96
-6.44%
After Hours: 14.25 +0.3 +2.15% 19:49 05/09 EDT
OPEN
14.80
PREV CLOSE
14.91
HIGH
15.01
LOW
13.14
VOLUME
587.05K
TURNOVER
--
52 WEEK HIGH
24.50
52 WEEK LOW
8.89
MARKET CAP
597.89M
P/E (TTM)
-10.9189
1D
5D
1M
3M
1Y
5Y
1D
Strong Performance and Growth Potential: Buy Rating for Beta Bionics, Inc.
TipRanks · 2d ago
12 Health Care Stocks Moving In Wednesday's Intraday Session
Benzinga · 2d ago
Beta Bionics price target lowered to $15 from $20 at Baird
TipRanks · 3d ago
Positive Developments and Strong Financial Performance Drive Buy Rating for Beta Bionics, Inc.
TipRanks · 3d ago
Beta Bionics Reports Strong Q1 2025 Results and Raises Guidance
TipRanks · 3d ago
Beta Bionics reports Q1 EPS (93c), consensus (51c)
TipRanks · 3d ago
Beta Bionics raises FY25 revenue view to $82M-$87M from $80M-$85M
TipRanks · 3d ago
Beta Bionics Q1 EPS $(0.93) Misses $(0.46) Estimate, Sales $17.64M Beat $16.15M Estimate
Benzinga · 3d ago
More
About BBNX
More
Beta Bionics, Inc. is a commercial-stage medical device company engaged in the design, development and commercialization of various solutions to improve the health of insulin-requiring people with diabetes (PWD). The Company's product, the iLet Bionic Pancreas (iLet), is an insulin delivery device cleared by the United States Food and Drug Administration (FDA) to utilize adaptive closed-loop algorithms to autonomously determine every insulin dose without requiring a user to count carbohydrate intake. iLet is used for the treatment of Type 1 diabetes (T1D). The Company's solutions include iLet for Adults, iLet for Children, Bionic Circle App and iLet Simulator. The Company is in the early stages of developing an insulin pump that is designed to adhere directly to the skin and administer insulin without the need for tubing, commonly known in the diabetes industry as a patch pump. It is also in the early stages of developing a bihormonal configuration of the iLet.
Recently
Symbol
Price
%Change
    CE
  • 51.21
  • -0.97%

Webull offers Beta Bionics, Inc. stock information, including NASDAQ: BBNX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, BBNX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading BBNX stock methods without spending real money on the virtual paper trading platform.